Smith Hunter C Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$3.01M

Insider Activity of Smith Hunter C

According to the SEC Form 4 filings, Smith Hunter C, being in a position of

  1. Chief Financial Officer at Rhythm Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 84427 shares for $8.84M,
    over all time since 2022-02-15, has bought 0 shares, and sold 263519 shares for $19.38M.

Biography of Smith Hunter C

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $8,837,0478100

Comparison of Insiders on Amount of Buys and Sells

2026-08-31SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
62,774
0.0909%
$105.46$6.62M-11.99%
2026-02-19SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
4,385
0.0066%
$101.26$444,004-9.84%
2026-02-17SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
3,569
0.0053%
$101.38$361,810-9.26%
2026-02-12SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
1,592
0.0024%
$98.23$156,380-2.94%
2026-02-11SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
2,766
0.0042%
$98.61$272,766-5.14%
2026-02-10SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
2,713
0.0041%
$103.00$279,429-9.18%
2026-02-05SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
3,381
0.0052%
$106.06$358,599-9.96%
2026-02-04SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
3,247
0.0048%
$105.99$344,145-13.33%
2025-08-13SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
3,477
0.0051%
$96.00$333,792+2.84%
2025-08-12SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
24,611
0.0378%
$96.33$2.37M+4.2%
2025-07-09SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
42,120
0.0599%
$80.48$3.39M+10.66%
2025-05-30SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
23,400
0.0368%
$61.41$1.44M+58.5%
2025-02-19SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
2,215
0.0036%
$57.22$126,742+65.9%
2025-02-12SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
751
0.0012%
$56.39$42,347+66.6%
2025-02-11SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
1,296
0.0021%
$57.51$74,533+66.53%
2025-02-04SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
1,678
0.0027%
$59.43$99,724+52.53%
2024-03-19SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
15,515
0.0259%
$39.22$608,498+26.61%
2024-02-13SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
709
0.0011%
$49.82$35,322-1.66%
2024-02-12SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
1,209
0.002%
$51.38$62,118-8.3%
2024-02-01SaleRhythm Pharmaceuticals, Inc.
RYTM
Chief Financial Officer
1,616
0.0027%
$45.06$72,817+2.85%
Total: 28
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.